Jeanette Dupont Jensen
Overview
Explore the profile of Jeanette Dupont Jensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gram-Nielsen R, Christensen I, Naghavi-Behzad M, Dahlsgaard-Wallenius S, Jakobsen N, Gerke O, et al.
J Imaging
. 2023 Oct;
9(10).
PMID: 37888329
The study aimed to compare the metastatic pattern of breast cancer and the intermodality proportion of agreement between [F]FDG-PET/CT and CE-CT. Women with metastatic breast cancer (MBC) were enrolled prospectively...
2.
Celik A, Berg T, Jensen M, Jakobsen E, Nielsen H, Kumler I, et al.
Breast Cancer (Auckl)
. 2023 Oct;
17:11782234231203292.
PMID: 37810797
Background: Metastatic triple-negative breast cancer (mTNBC) is an aggressive subtype of breast cancer with poor survival. Currently, the literature lacks comprehensive real-world evidence on locally recurrent and mTNBC patients. To...
3.
Vogsen M, Naghavi-Behzad M, Harbo F, Jakobsen N, Gerke O, Asmussen J, et al.
Sci Rep
. 2023 Apr;
13(1):5552.
PMID: 37019987
Trial Registration: Clinical. Trials: gov. NCT03358589. Registered 30/11/2017-Retrospectively registered, http://www. Clinicaltrials: gov.
4.
Reznitsky F, Jensen J, Knoop A, Laenkholm A
APMIS
. 2022 May;
130(9):545-550.
PMID: 35639634
Tumor infiltrating lymphocytes (TILs) have predictive and prognostic potential in HER2-positive breast cancer (HER2 + BC). Due to tumor heterogeneity, guidelines recommend evaluation on full tumor-sections over biopsies, but aren't...
5.
Vogsen M, Jensen J, Gerke O, Bak Jylling A, Asmussen J, Christensen I, et al.
EJNMMI Res
. 2021 Sep;
11(1):93.
PMID: 34553294
Background: [F]-fluorodeoxyglucose-positron emission tomography/computed tomography ([F]FDG-PET/CT) has been implemented sporadically in hospital settings as the standard of care examination for recurrent breast cancer. We aimed to explore the clinical impact...
6.
Dieperink K, Ellegaard E, Astrup A, Hasse H, Elnegaard C, Jensen J
Nurs Open
. 2020 Dec;
8(1):423-433.
PMID: 33318850
Aim: To investigate outpatients with breast cancer perception of information before and after changed informational practice. Design: The design was a comparative study. Method: Information about breast cancer treatment and...
7.
Halberg A, Gravesen C, Cold S, Jensen J
Dan Med J
. 2020 Dec;
67(12).
PMID: 33269690
Introduction: Neoadjuvant chemotherapy (NACT) has been found useful in downstaging tumours in women with primary operable breast cancer without increasing mortality. As a result of several studies supporting this, the...
8.
Vogsen M, Jensen J, Christensen I, Gerke O, Bak Jylling A, Larsen L, et al.
Breast Cancer Res Treat
. 2020 Sep;
185(1):145-153.
PMID: 32920740
Purpose: To investigate the clinical impact of FDG-PET/CT for staging and treatment planning in high-risk primary breast cancer. Methods: Women with high-risk primary breast cancer were enrolled between September 2017...
9.
Jensen M, Laenkholm A, Balslev E, Buckingham W, Ferree S, Glavicic V, et al.
NPJ Breast Cancer
. 2020 Mar;
6:7.
PMID: 32140564
The DBCG89D trial randomized high-risk early breast cancer patients to adjuvant CMF (cyclophosphamide, methotrexate and fluorouracil) or CEF (cyclophosphamide, epirubicin and fluorouracil). Prosigna assays were performed by researchers with no...
10.
Rosenbaek F, Holm H, Hjelmborg J, Ewertz M, Jensen J
Support Care Cancer
. 2019 Dec;
28(8):3763-3769.
PMID: 31828491
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity of paclitaxel. Though no pharmacological agents have been identified to prevent CIPN, cryotherapy with frozen gloves and socks may reduce the...